Medimix Hematology
  • Home
  • Live from the congress
    • 2025
      • EBMT 2025
    • 2024
      • ASH 2024 (San Diego)
      • EHA 2024 (Madrid)
      • ASCO 2024 (Chicago)
  • Contact
  • Other specialties
    • Dermatology
    • Oncology
  • SIGN UP
  • SIGN IN
    • Login
EHA 2024

IMPACT-AML project

July 2, 2024

Presented by Prof Dr Giovanni Martinelli (“L. e A. Seragnoli” Institute, Bologna, Italy)

Prof Dr Giovanni Martinelli, a haematologist at the “L. e A. Seragnoli” Institute in Bologna, Italy, presented Impact-AML, a European master framework designed for cohort studies and pragmatic clinical trials in R/R AML. The primary goals of this initiative are to establish an inclusive framework for R/R AML patients, design and conduct a randomized pragmatic clinical trial comparing low-intensity and standard chemotherapy rescue, and increase patient engagement in clinical trials. Additionally, standard operating procedures for local biobanking will be developed, including sample collection for MRD quantification, to enhance biological understanding of R/R AML

References:

https://impactaml.eu 

With the educational support of:

Back to congress overview

Tags:

in-depth

Share Article

Medimix Hematology

Website created by MediMix © 2025 - Privacy Policy

  • Home
  • Live from the congress
    • 2025
      • EBMT 2025
    • 2024
      • ASH 2024 (San Diego)
      • EHA 2024 (Madrid)
      • ASCO 2024 (Chicago)
  • Contact
  • Other specialties
    • Dermatology
    • Oncology
  • SIGN UP
  • SIGN IN
    • Login
    • Logout
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok